Eric Venker - 01 Oct 2021 Form 3 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
President & COO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol
ROIV
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
3
Filing time
01 Oct 2021, 17:38:59 UTC
Next filing
29 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ROIV Common Shares 1,388,993 01 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 260,326 $7.45 Direct F2, F8
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 70,702 $7.99 Direct F3, F8
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 292,620 $10.96 Direct F4, F8
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 1,181,883 $15.85 Direct F5, F8
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 438,930 $13.07 Direct F6, F8
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 1,969,557 $10.00 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) an award of 438,930 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of May 20, 2020 and (ii) an award of 950,063 RSUs with a vesting commencement date of May 20, 2021. These awards of RSUs service-vest (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.
F2 Award of stock options to purchase Common Shares with a vesting commencement date of October 16, 2017.
F3 Award of stock options to purchase Common Shares with a vesting commencement date of May 21, 2018.
F4 Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2019.
F5 Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019.
F6 Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2020.
F7 Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2021.
F8 Awards of stock options to purchase Common Shares vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney